Indications and donor selections for allogeneic stem cell transplantation in children with hematologic malignancies.

Published

Journal Article (Review)

Allogeneic stem cell transplantation (SCT) is the only curative approach for many patients with advanced or high-risk leukemia. Advances in supportive care and management of graft-versus-host disease have resulted in improvements in outcomes of related and unrelated donor SCT, creating controversies as to which strategy might be the optimal therapy for individual patients. This article discusses the indications and donor selection strategies for SCT in patients with malignant hematologic disease.

Full Text

Duke Authors

Cited Authors

  • Handgretinger, R; Kurtzberg, J; Egeler, RM

Published Date

  • February 2008

Published In

Volume / Issue

  • 55 / 1

Start / End Page

  • 71 - x

PubMed ID

  • 18242316

Pubmed Central ID

  • 18242316

International Standard Serial Number (ISSN)

  • 0031-3955

Digital Object Identifier (DOI)

  • 10.1016/j.pcl.2007.10.013

Language

  • eng

Conference Location

  • United States